
Sergio Coffa
Examiner (ID: 9433, Phone: (571)270-3022 , Office: P/1675 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1676, 1658, 1675, 1654 |
| Total Applications | 931 |
| Issued Applications | 452 |
| Pending Applications | 139 |
| Abandoned Applications | 357 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18739583
[patent_doc_number] => 20230348539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => A NEW ANTIBIOTIC SELECTIVELY KILLS GRAM-NEGATIVE PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 17/778785
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778785
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/778785 | Antibiotic selectively kills gram-negative pathogens | Nov 19, 2020 | Issued |
Array
(
[id] => 16977623
[patent_doc_number] => 20210221860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => APPLICATION OF RECOMBINANT HUMAN SECRETORY DDRGK1
[patent_app_type] => utility
[patent_app_number] => 16/952391
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4841
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952391
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/952391 | Use of recombinant human secretory DDRGK1 | Nov 18, 2020 | Issued |
Array
(
[id] => 16839484
[patent_doc_number] => 20210147496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => PEPTIDES, HYDROGEL COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/098629
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098629
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098629 | Peptides, hydrogel compositions and methods of use thereof | Nov 15, 2020 | Issued |
Array
(
[id] => 16824255
[patent_doc_number] => 20210139548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => NPY2 RECEPTOR AGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/093680
[patent_app_country] => US
[patent_app_date] => 2020-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17093680
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/093680 | NPY2 RECEPTOR AGONISTS | Nov 9, 2020 | Abandoned |
Array
(
[id] => 18545314
[patent_doc_number] => 11718654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => IL-2R-bg binding compounds
[patent_app_type] => utility
[patent_app_number] => 17/089515
[patent_app_country] => US
[patent_app_date] => 2020-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 69
[patent_no_of_words] => 75601
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17089515
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/089515 | IL-2R-bg binding compounds | Nov 3, 2020 | Issued |
Array
(
[id] => 16807871
[patent_doc_number] => 20210130424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => DUAL IL-2R AND IL-7R BINDING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/089533
[patent_app_country] => US
[patent_app_date] => 2020-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 122677
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17089533
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/089533 | Dual IL-2R and IL-7R binding compounds | Nov 3, 2020 | Issued |
Array
(
[id] => 17119661
[patent_doc_number] => 11130783
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-28
[patent_title] => CD40 targeted peptides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/089463
[patent_app_country] => US
[patent_app_date] => 2020-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 75269
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17089463
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/089463 | CD40 targeted peptides and uses thereof | Nov 3, 2020 | Issued |
Array
(
[id] => 16629594
[patent_doc_number] => 20210048247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => METHOD OF MICROWAVE VACUUM DRYING SPHERICAL-SHAPED PELLETS OF BIOLOGICAL MATERIALS
[patent_app_type] => utility
[patent_app_number] => 17/081484
[patent_app_country] => US
[patent_app_date] => 2020-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9044
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17081484
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/081484 | METHOD OF MICROWAVE VACUUM DRYING SPHERICAL-SHAPED PELLETS OF BIOLOGICAL MATERIALS | Oct 26, 2020 | Abandoned |
Array
(
[id] => 18064470
[patent_doc_number] => 20220395557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => METHODS FOR TREATING PATIENTS HAVING CFH MUTATIONS WITH RECOMBINANT CFH PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/771334
[patent_app_country] => US
[patent_app_date] => 2020-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -77
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17771334
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/771334 | METHODS FOR TREATING PATIENTS HAVING CFH MUTATIONS WITH RECOMBINANT CFH PROTEINS | Oct 22, 2020 | Abandoned |
Array
(
[id] => 18027803
[patent_doc_number] => 11510964
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => Macrocyclic peptides to decrease c-Myc protein levels and reduce cancer cell growth
[patent_app_type] => utility
[patent_app_number] => 17/072409
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 39
[patent_no_of_words] => 13707
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17072409
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/072409 | Macrocyclic peptides to decrease c-Myc protein levels and reduce cancer cell growth | Oct 15, 2020 | Issued |
Array
(
[id] => 16868535
[patent_doc_number] => 20210162002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF SPINAL CORD INJURY AND ALS
[patent_app_type] => utility
[patent_app_number] => 17/072951
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38179
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17072951
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/072951 | REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF SPINAL CORD INJURY AND ALS | Oct 15, 2020 | Abandoned |
Array
(
[id] => 18254330
[patent_doc_number] => 20230081369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => IFIT Polypeptides and Uses for Treating Tuberculosis Infection
[patent_app_type] => utility
[patent_app_number] => 17/767734
[patent_app_country] => US
[patent_app_date] => 2020-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11350
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767734
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/767734 | IFIT Polypeptides and Uses for Treating Tuberculosis Infection | Oct 7, 2020 | Pending |
Array
(
[id] => 18241470
[patent_doc_number] => 20230073781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => Systemic administration of peptides for the treatment of spinal cord injury and/or for remyelination
[patent_app_type] => utility
[patent_app_number] => 17/767099
[patent_app_country] => US
[patent_app_date] => 2020-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767099
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/767099 | Systemic administration of peptides for the treatment of spinal cord injury and/or for remyelination | Oct 6, 2020 | Pending |
Array
(
[id] => 17052179
[patent_doc_number] => 20210261613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
[patent_app_type] => utility
[patent_app_number] => 17/064937
[patent_app_country] => US
[patent_app_date] => 2020-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17064937
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/064937 | AROMATIC-CATIONIC PEPTIDES AND USES OF SAME | Oct 6, 2020 | Abandoned |
Array
(
[id] => 18368141
[patent_doc_number] => 11648289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-16
[patent_title] => Antibacterial method
[patent_app_type] => utility
[patent_app_number] => 17/060648
[patent_app_country] => US
[patent_app_date] => 2020-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16855
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17060648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/060648 | Antibacterial method | Sep 30, 2020 | Issued |
Array
(
[id] => 16598057
[patent_doc_number] => 20210024588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => ANTIBACTERIAL METHOD
[patent_app_type] => utility
[patent_app_number] => 17/060592
[patent_app_country] => US
[patent_app_date] => 2020-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16690
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17060592
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/060592 | ANTIBACTERIAL METHOD | Sep 30, 2020 | Abandoned |
Array
(
[id] => 19050867
[patent_doc_number] => 20240092836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => CYCLIC PEPTIDE HAVING CTLA-4 INHIBITORY ACTIVITY AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/767550
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24690
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767550
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/767550 | Cyclic peptide having CTLA-4 inhibitory activity and use thereof | Sep 29, 2020 | Issued |
Array
(
[id] => 18004857
[patent_doc_number] => 20220363623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => IMAGING AND THERAPEUTIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/642505
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17642505
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/642505 | IMAGING AND THERAPEUTIC COMPOSITIONS | Sep 17, 2020 | Pending |
Array
(
[id] => 16870090
[patent_doc_number] => 20210163557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE AND IMPROVING NORMAL MEMORY
[patent_app_type] => utility
[patent_app_number] => 17/018450
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17018450
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/018450 | METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE AND IMPROVING NORMAL MEMORY | Sep 10, 2020 | Abandoned |
Array
(
[id] => 17867059
[patent_doc_number] => 20220289794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => SYNTHETIC ANTIMICROBIAL PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/639082
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -70
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17639082
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/639082 | SYNTHETIC ANTIMICROBIAL PEPTIDES | Aug 30, 2020 | Abandoned |